Eocene Ltd Shs Par $1.80 (New) (EOCN:NASDAQ) closed at $3.12 on October 21, 2026, unchanged on the day. The stock trades 74.7% below its 52-week high of $12.32 and 33.9% above its 52-week low of $2.33. Over the past year, it lost 32.9%. Eocene Ltd Shs Par $1.80 (New) is part of the Basic Materials sector.
In 147 trading sessions since March 24, 2026, EOCN closed higher on 63 days (43%). Its best day was April 9, 2026 (+26.21%) and its worst was June 8, 2026 (-32.61%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 4 times.
EoCene Ltd. (NASDAQ: EOCN) is a GI-focused medtech and biopharmaceutical company headquartered in Ramat Gan, Israel, dedicated to advancing innovative solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. The Company is building a diversified platform that combines medical devices, therapeutics and enabling technologies to address significant unmet clinical needs and improve patient outcomes. EoCene's wholly owned subsidiary, Colospan Ltd., is a commercial-stage medical device company developing solutions designed to transform postoperative colorectal care. Its flagship product, CG-100, is an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas, offering a less invasive alternative to current surgical practice.
Find more stocks like EOCN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.